Epidemiology of hepatitis D virus (HDV) infection in an urban area of Northern Italy

Infection

Volumn 40, Issue 5, 2012, Pages 485-491

  De Paschale, M ^a   Manco, M T ^a   Belvisi, L ^a   Magnani, C ^a   Re, T ^a   Vigano P ^a   Biagiotti, S ^a   Capelli, F ^a   Mazzone, A ^a   Baldacci, M P ^a   Ferrara, A ^a   Neri, A L ^a   Guastoni, C M ^a   Bonazzina, R A ^a   Brando, B ^a   Clerici, P ^a  

^a Hospital of Legnano   (Italy)

Author keywords

Anti HD antibodies; HDV infection; Italian patients; Non Italian patients

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS DELTA ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DELTA AGENT HEPATITIS; DISEASE SURVEILLANCE; FEMALE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFANT; INTRAVENOUS DRUG ABUSE; ITALY; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; PREVALENCE; SCHOOL CHILD; SEX DIFFERENCE; URBAN AREA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS D; HEPATITIS D, CHRONIC; HEPATITIS DELTA VIRUS; HUMANS; INFANT; ITALY; MALE; MIDDLE AGED; PREVALENCE; SUBSTANCE ABUSE, INTRAVENOUS; URBAN POPULATION;

EID: 84867745009     PISSN: 03008126     EISSN: 14390973     Source Type: Journal    
DOI: 10.1007/s15010-012-0247-4     Document Type: Article

References (38)

1. Smedile A, Lavorini C, Farci P, et al. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol. 1983;117:223-9.
2. Sagnelli E, Stroffolini T, Ascione A, et al. The epidemiology of hepatitis delta infection in Italy. J Hepatol. 1992;15:211-5.
3. Giusti G, Sagnelli E, Gallo C, et al. The etiology of chronic hepatitis in Italy: a multicentre study. Hepatogastroenterology. 1994;41:397-400.
4. Rizzetto M, Verme G, Recchia S, et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med. 1993;98:437-41.
5. Hadziyannis SJ, Hatzakis A, Papaioannou C, et al. Endemic hepatitis delta virus infection in a Greek community. Prog Clin Biol Res. 1987;234:181-202.
6. Rosina F, Conoscitore P, Cuppone R, et al. Changing pattern of chronic hepatitis D in Southern Europe. Gastroenterology. 1999;117:161-6.
7. Romanò L, Paladini S, Tagliacarte C, et al. The changing face of the epidemiology of type A, B, and D viral hepatitis in Italy, following the implementation of vaccination. Vaccine. 2009;27: 3439-42.
8. Rizzetto M, Hadziyannis S, Hansson BG, et al. Hepatitis delta virus infection in the world: epidemiological patterns and clinical expression. Gastroenterol Int. 1992;5:18-32.
9. Dëgertekin H, Yalçin K, Yakut M, Yurdaydin C. Seropositivity for delta hepatitis in patients with chronic hepatitis B and liver cirrhosis in Turkey: a meta-analysis. Liver Int. 2008;28:494-8.
10. Hadziyannis SJ, Dourakis SP, Papaioannou C, et al. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece. Prog Clin Biol Res. 1993;382:259-66.
11. Navascués CA, Rodriguez M, Sotorrio NG, et al. Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol. 1995;11:1981-4.
12. Dëgertekin H, YalçinK, Yakut M. The prevalence of hepatitis delta virus infection in acute and chronic liver diseases in Turkey: an analysis of clinical studies. Turk J Gastroenterol. 2006;17:25-34.
13. Le Gal F, Castelneau C, Gault E, et al. Hepatitis D virus infection - not a vanishing disease in Europe! Hepatology. 2007;45:1332-3.
14. Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection - not a vanishing disease in Europe! Hepatology. 2007;45: 1331-2.
15. Erhardt A, Knuth R, Sagir A, et al. Socioepidemiological data on hepatitis delta in a German university clinic - increase in patients from Eastern Europe and the former Soviet Union. Z Gastroenterol. 2003;41:523-6.
16. Wedemeyer H, Hepatitis D. revival. Liver Int. 2011;31[Suppl 1]:140-4.
17. Cross TJ, Rizzi P, Horner M, et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol. 2008;80:277-82.
18. Rizzetto M. Hepatitis D: the comeback? Liver Int. 2009;29[Suppl 1]:140-2.
19. Raimondo G, Smedile A, Gallo L, et al. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet. 1982;1:249-51.
20. Niro GA, Casey JL, Gravinese E, et al. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol. 1999;30: 564-9.
21. D'Amelio R, Matricardi PM, Biselli R, et al. Changing epidemiology of hepatitis B in Italy: public health implications. Am J Epidemiol. 1992;135:1012-8.
22. Gaeta GB, Stroffolini T, Chiaramonte M, et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology. 2000;32:824-7.
23. Stroffolini T. The changing pattern of hepatitis B virus infection over the past three decades in Italy. Dig Liver Dis. 2005;37: 622-7.
24. Mele A, Mariano A, Tosti ME, et al. Acute hepatitis Delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. Clin Infect Dis. 2007;44:17-24.
25. Zanetti AR, Tanzi E, Romanò L, Grappasonni I. Vaccination against hepatitis B: the Italian strategy. Vaccine. 1993;11:521-4.
26. Sagnelli E, Stroffolini T, Mele A, et al. Chronic hepatitis B in Italy: new features of an old disease - approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. Clin Infect Dis. 2008;46:110-3.
27. Gaeta GB, Stroffolini T, Smedile A, et al. Hepatitis delta in Europe: vanishing or refreshing? Hepatology. 2007;46:1312-3.
28. Stroffolini T, Almasio PL, Sagnelli E, et al. Evolving clinical landscape of chronic hepatitis B: a multicenter Italian study. J Med Virol. 2009;81:1999-2006.
29. Gaeta GB, Precone DF, Cozzi-Lepri A, et al. Multiple viral infections. J Epatol. 2006;44[Suppl 1]:S108-13.
30. Mocroft A, Soriano V, Rockstroh J, et al. Is there evidence for an increase in the death rate from liver-related disease in patients with HIV? AIDS. 2005;19:2117-25.
31. Raimondo G, Isgro G, Caccamo G, et al. Is there a downgrading in the alert about the hepatitis B virus infection in Italy? Dig Liver Dis. 2007;39:257-61.
32. Gaiani S, Gramantieri L, Venturoli N, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol. 1997;27:979-85.
33. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-36.
34. Villa E, Fattovich G, Mauro A, Pasino M. Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis. Dig Liver Dis. 2011;43[Suppl 1]:S8-14.
35. Torre F, Basso M, Giannini EG, et al. Clinical and virological survey of patients with hepatitis B surfage antigen in an Italian region: clinical consideration and disease burden. J Med Virol. 2009;81:1882-6.
36. EASL European Association For The Study Of The Liver. Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol. 2009;50:227-42.
37. Wedemeyer H, Yurdaydìn C, Dalekos GN, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med. 2011;364:322-31.
38. Romeo R, Del Ninno E, Rumi M, et al. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009;136:1629-38.